A
Agilent Technologies·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About A
Agilent Technologies, Inc.
A global leader in the life sciences, diagnostics, and applied chemical markets
Life Science Tools and Services
--
11/18/1999
New York Stock Exchange
17,900
10-31
Common stock
5301 Stevens Creek Blvd., Santa Clara, California 95051
Life Sciences, Diagnostics and Applied Chemistry Markets Provide Services and Consumables
Incorporated in Delaware in May 1999, Agilent Technologies, Inc. is a global leader in the life sciences, diagnostic and applied chemistry markets, providing application-centric solutions for the entire laboratory workflow, including instruments, software, services and consumables. For the fiscal year ending October 31, 2023, the company has three business segments, including life sciences and applied markets business, diagnostic and genomics business and Agilent cross-labs business.
Earnings Call
Q3/2025
Estimate EPS1.37
Actual EPS1.37
Estimate Revenue1.67B
Actual Revenue1.74B
Agilent's Q3 2025 Earnings Call: Contradictions Emerge on Tariff Impact, Pricing Strategies, and Instrument Replacement Cycle
Aug 28,2025 05:13
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
A has released its 2025 Q4 earnings. EPS was reported at 1.59, versus the expected 1.58, beating expectations. The chart below visualizes how A has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
A has released its 2025 Q4 earnings report, with revenue of 1.86B, reflecting a YoY change of 9.41%, and net profit of 434.00M, showing a YoY change of 23.65%. The Sankey diagram below clearly presents A's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
